Loading stock data...

Abbott India Limited

NSE: ABBOTINDIA BSE: ABBOTINDIA

NSE
30,955.00 -25.00 (-0.08%)

Prev Close

30980

Open Price

30900

Volume

4,757

Today Low / High

30895 / 31400

52 WK Low / High

25325 / 37000

Range

29,407 - 32,503

BSE
30,991.95 28.65 (0.09%)

Prev Close

30963.3

Open Price

31125

Volume

252

Today Low / High

30914.2 / 31395.9

52 WK Low / High

25260.2 / 35921.55

Range

29,442 - 32,542

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 30955 (target range: 29,407 - 32,503), reflecting a change of -25 (-0.08069722%). On the BSE, it is listed at 30991.95 (target range: 29,442 - 32,542), showing a change of 28.65 (0.0925289%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

12 Sep 31,100.00 -0.39%
11 Sep 31,385.00 -1.31%
10 Sep 30,825.00 1.39%
09 Sep 31,000.00 -1.19%
08 Sep 31,415.00 -1.43%
05 Sep 32,385.00 -3.81%
04 Sep 32,565.00 -1.20%
03 Sep 32,495.00 0.25%
02 Sep 32,300.00 0.60%
01 Sep 31,650.00 1.52%
29 Aug 31,660.00 -0.57%
28 Aug 32,000.00 -1.64%
26 Aug 31,615.00 0.85%
25 Aug 32,145.00 -1.94%
22 Aug 32,745.00 -2.66%
21 Aug 32,895.00 -0.79%

Abbott India Limited Graph

Abbott India Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Abbott India Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 30,955.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 30,991.95 31,301.87 28,171.68 - 34,432.06
31,611.79 25,289.43 - 37,934.15
31,921.71 22,345.20 - 41,498.22
Bearish Scenario 30,991.95 30,682.03 27,613.83 - 33,750.23
30,372.11 24,297.69 - 36,446.53
30,062.19 21,043.53 - 39,080.85

Overview of Abbott India Limited

ISIN

INE358A01014

Industry

Drug Manufacturers - General

Vol.Avg

9,108

Market Cap

658,303,314,000

Last Dividend

475

Official Website

Visit Website

IPO Date

2002-08-12

DCF Diff

-58,450.46

DCF

90,325

Financial Ratios Every Investor Needs

Stock Dividend of ABBOTINDIA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-07-25 July 25, 25 475 475 2025-07-25 2025-09-12
2024-07-19 July 19, 24 410 410 2024-07-19 2024-09-07
2023-07-21 July 21, 23 145 145 2023-07-21 2023-09-08
2022-08-02 August 02, 22 130 130 2022-08-03 2022-09-09
2021-07-19 July 19, 21 155 155 2021-07-20 2021-08-26

Stock Rating Details for ABBOTINDIA

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 6,409.15 Cr 3,496.78 Cr 2,912.37 Cr 0.4544 1.04 Cr 148.47 Cr 1,622.80 Cr 1,414.44 Cr 665.62 1,970.18 Cr 0.2207
2024-03-31 5,847.19 Cr 3,232.69 Cr 2,614.50 Cr 0.4471 0.96 Cr 126.69 Cr 1,405.54 Cr 1,201.22 Cr 565.30 1,697.80 Cr 0.2054
2023-03-31 5,346.73 Cr 2,986.08 Cr 2,360.65 Cr 0.4415 0.79 Cr 131.67 Cr 1,147.27 Cr 949.41 Cr 446.80 1,356.03 Cr 0.1776
2022-03-31 4,910.30 Cr 2,667.94 Cr 2,242.36 Cr 0.4567 0.81 Cr 158.40 Cr 1,025.92 Cr 798.70 Cr 375.87 1,161.25 Cr 0.1627
2021-03-31 4,307.59 Cr 2,400.28 Cr 1,907.31 Cr 0.4428 0.84 Cr 134.22 Cr 872.22 Cr 690.69 Cr 325.04 998.26 Cr 0.1603

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 560.59 Cr 5,917.31 Cr 1,684.16 Cr 4,233.1500 Cr 196.67 Cr -363.92 Cr 882.04 Cr 347.60 Cr 0.00 Cr 0.00 Cr 743.24 Cr 1,407.1900 Cr
2024-03-31 291.74 Cr 5,193.49 Cr 1,494.60 Cr 3,698.8900 Cr 83.23 Cr -208.51 Cr 619.58 Cr 228.39 Cr 7.40 Cr 0.00 Cr -169.73 Cr 1,342.7200 Cr
2023-03-31 239.67 Cr 4,555.51 Cr 1,366.97 Cr 3,188.5400 Cr 113.17 Cr -126.50 Cr 648.85 Cr 233.05 Cr 4.71 Cr 0.00 Cr -460.66 Cr 1,206.0200 Cr
2022-03-31 132.71 Cr 4,224.12 Cr 1,404.33 Cr 2,819.7900 Cr 151.69 Cr 18.98 Cr 687.82 Cr 263.03 Cr 4.07 Cr 0.00 Cr -2,575.42 Cr 1,203.1900 Cr
2021-03-31 218.27 Cr 3,840.45 Cr 1,238.29 Cr 2,602.1600 Cr 152.58 Cr -65.69 Cr 717.59 Cr 250.27 Cr 0.00 Cr 0.00 Cr 46.62 Cr 1,030.8600 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 1,011.8400 Cr 182.1800 Cr -925.1700 Cr 959.2400 Cr 268.8500 Cr 560.5900 Cr -52.6000 Cr 1,886.9500 Cr -53.8900 Cr -871.2200 Cr -262.4700 Cr
2024-03-31 1,212.8100 Cr -559.6600 Cr -744.7100 Cr 1,164.4800 Cr 52.0700 Cr 291.7400 Cr -48.3300 Cr 1,201.2200 Cr 0.0000 Cr -690.6000 Cr 29.2600 Cr
2023-03-31 893.3900 Cr -147.7100 Cr -638.7200 Cr 859.2800 Cr 106.9600 Cr 239.6700 Cr -34.1100 Cr 1,273.8200 Cr 0.0000 Cr -584.3600 Cr 38.9700 Cr
2022-03-31 947.6600 Cr -395.8400 Cr -637.3800 Cr 903.5900 Cr -85.5600 Cr 132.7100 Cr -44.0700 Cr 1,079.7300 Cr 0.0000 Cr -584.3600 Cr 29.7800 Cr
2021-03-31 726.7400 Cr -71.8200 Cr -581.7900 Cr 703.4300 Cr 73.1300 Cr 218.2700 Cr -23.3100 Cr 925.9500 Cr 0.0000 Cr -531.2300 Cr -190.4200 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 1,738.35 Cr 942.12 Cr 796.23 Cr 0.4580 426.11 Cr 365.86 Cr 172.17 518.43 Cr 0.2105
2025-03-31 1,604.59 Cr 855.96 Cr 748.63 Cr 0.4666 410.61 Cr 367.04 Cr 172.72 504.56 Cr 0.2287
2024-12-31 1,614.28 Cr 892.70 Cr 721.58 Cr 0.4470 418.10 Cr 360.78 Cr 169.78 507.84 Cr 0.2235
2024-09-30 1,632.67 Cr 901.76 Cr 730.91 Cr 0.4477 421.45 Cr 358.61 Cr 168.76 499.44 Cr 0.2196
2024-06-30 1,557.61 Cr 1,025.79 Cr 531.82 Cr 0.3414 372.64 Cr 328.01 Cr 154.36 458.34 Cr 0.2106

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 560.59 Cr 2,552.59 Cr 3,409.25 Cr 380.23 Cr 882.04 Cr 4,765.11 Cr 350.54 Cr 5,917.31 Cr 1,684.16 Cr
2024-12-31 0.00 Cr 0.00 Cr 1,105.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -3,521.11 Cr
2024-09-30 637.69 Cr 1,247.99 Cr 1,885.68 Cr 394.77 Cr 739.14 Cr 3,107.30 Cr 221.07 Cr 5,063.02 Cr 1,541.91 Cr
2024-06-30 0.00 Cr 0.00 Cr 2,117.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -3,698.89 Cr
2024-03-31 291.74 Cr 1,826.25 Cr 2,117.99 Cr 460.59 Cr 619.58 Cr 3,245.84 Cr 228.39 Cr 5,193.49 Cr 1,494.60 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 367.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 360.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 358.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 328.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 287.06 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,554.40 ₹1,255,572,792,730.00 ₹457,203.00
Abbott India Limited ABBOTINDIA ₹30,945.00 ₹657,559,588,500.00 ₹4,495.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,756.70 ₹467,001,520,200.00 ₹38,833.00
Gland Pharma Limited GLAND ₹2,010.40 ₹331,225,462,400.00 ₹192,326.00
Pfizer Limited PFIZER ₹5,154.00 ₹235,783,645,800.00 ₹10,117.00
Sanofi India Limited SANOFI ₹5,048.50 ₹116,266,955,000.00 ₹8,599.00
Marksans Pharma Limited MARKSANS ₹174.17 ₹78,927,573,880.00 ₹457,132.00

Key Executives

Company Secretary & Compliance Officer
Ms. Sangeeta Mukesh Shetty

Gender: female

Year Born:

Director of Business Human Resources
Mr. Rajan Kalantre

Gender: male

Year Born:

MD & Director
Ms. Swati Dalal

Gender: female

Year Born:

Chief Financial Officer
Ms. Maithilee Mistry

Gender: female

Year Born:

FAQs about Abbott India Limited

Who is the CEO of the company?

The CEO is Swati Dalal.

What is the current market price of the stock?

The current price is ₹30,980.00.

What is the 52-week price range?

The range is ₹25325-37000.

What is the market capitalization of the company?

The market capitalization is ₹65,830.33 crores.

What is the dividend yield?

The dividend yield is 1.53%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 45.33.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Abbott India Limited (ISIN: INE358A01014) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹65,830.33 crores and an average daily volume of 9,108 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹475.